Literature DB >> 11156385

Genetic heterogeneity in familial juvenile polyposis.

S C Huang1, C R Chen, J E Lavine, S F Taylor, R O Newbury, T T Pham, L Ricciardiello, J M Carethers.   

Abstract

Juvenile polyposis syndrome (JPS) is an autosomal dominant syndrome characterized by multiple gastrointestinal hamartomatous polyps in the absence of the extraintestinal features that are classic for other hamartomatous polyposis syndromes, such as Bannayan-Riley-Ruvalcaba syndrome (BRRS) and Cowden disease (CD). About 50% of BRRS and >80% of CD demonstrate germ-line mutations in the tumor suppressor and dual phosphatase, PTEN. Germ-line mutation of PTEN as a cause for JPS in a child is controversial because extraintestinal manifestations that would exclude JPS could appear after adolescence, altering the clinical diagnosis. Here, we investigated a family in which the 55-year-old father, who lacks thyroid or skin findings characteristic of CD, demonstrated a germ-line mutation in PTEN that was passed to identical twin daughters, who both manifested JPS. The mutation was a deletion of five bases beginning seven bases from the start of exon 4 of PTEN, which caused aberrant transcripts by reverse transcription-PCR that were absent from a normal individual. Thus, mutations in PTEN are associated with JPS in addition to CD and some BRRS families, although the incidence of PTEN germ-line mutations in JPS might be more rare than that reported for SMAD4, a gene found to be mutated in approximately one-half of the JPS families investigated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156385

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Bone morphogenetic protein signaling and growth suppression in colon cancer.

Authors:  Stayce E Beck; Barbara H Jung; Antonio Fiorino; Jessica Gomez; Eunice Del Rosario; Betty L Cabrera; Sherry C Huang; Jimmy Y C Chow; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07       Impact factor: 4.052

2.  Evidence for an hMSH3 defect in familial hamartomatous polyps.

Authors:  Sherry C Huang; Jeffrey K Lee; E Julieta Smith; Ryan T Doctolero; Akihiro Tajima; Stayce E Beck; Noel Weidner; John M Carethers
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

3.  Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.

Authors:  Yi-Ling Li; Zhong Tian; Dong-Ying Wu; Bao-Yu Fu; Yan Xin
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

4.  BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.

Authors:  Stayce E Beck; Barbara H Jung; Eunice Del Rosario; Jessica Gomez; John M Carethers
Journal:  Cell Signal       Date:  2007-01-24       Impact factor: 4.315

5.  High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome.

Authors:  S Aretz; D Stienen; S Uhlhaas; M Stolte; M M Entius; S Loff; W Back; A Kaufmann; K-M Keller; S H Blaas; R Siebert; S Vogt; S Spranger; E Holinski-Feder; L Sunde; P Propping; W Friedl
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

6.  TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.

Authors:  Jimmy Y C Chow; Jennifer A Cabral; Jessica Chang; John M Carethers
Journal:  Cancer Biol Ther       Date:  2008-10-22       Impact factor: 4.742

Review 7.  New insights into the aetiology of colorectal cancer from genome-wide association studies.

Authors:  Albert Tenesa; Malcolm G Dunlop
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

Review 8.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

9.  RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.

Authors:  Jimmy Y C Chow; Khai T Quach; Betty L Cabrera; Jennifer A Cabral; Stayce E Beck; John M Carethers
Journal:  Carcinogenesis       Date:  2007-07-17       Impact factor: 4.944

10.  Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer.

Authors:  C Mamot; G Mild; J Reuter; U Laffer; U Metzger; L Terracciano; J-L Boulay; R Herrmann; C Rochlitz
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.